Advancing Clinical Trials to Streamline Drug Development (Q46111530)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2015

edit

Language	Label	Description	Also known as
English	Advancing Clinical Trials to Streamline Drug Development	scientific article published in October 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

editorial

0 references

title

Advancing Clinical Trials to Streamline Drug Development (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

author

Sanjeeve Balasubramaniam

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

Susan E Bates

series ordinal

1

object named as

Susan E Bates

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

author name string

Donald A Berry

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

Stuart Bailey

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

Patricia M LoRusso

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

Eric H Rubin

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

language of work or name

English

0 references

publication date

1 October 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

volume

21

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

issue

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

page(s)

4527-4535

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

cites work

The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Next-Generation Sequencing to Guide Clinical Trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Pembrolizumab: first global approval

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Basics of case report form designing in clinical research

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

First FDA approval of neoadjuvant therapy for breast cancer: pertuzumab for the treatment of patients with HER2-positive breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Adaptive clinical trials in oncology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Dose escalation methods in phase I cancer clinical trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Critical aspects of the Bayesian approach to phase I cancer trials.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Translation of innovative designs into phase I trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

The protein kinase complement of the human genome

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Oncogenic kinase signalling

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Cancer phase I clinical trials: efficient dose escalation with overdose control.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

A comparison of two phase I trial designs.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Continual reassessment method: a practical design for phase 1 clinical trials in cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

A sequential phase II/III trial for binary outcomes.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6063985

retrieved

26 August 2018

Clinical trials: More trials, fewer tribulations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26473188

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical modifications of the continual reassessment method for phase I cancer clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26473188

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failures in Phase III: Causes and Consequences

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26473188

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expansion Cohorts in First-in-Human Solid Tumor Oncology Trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26473188

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1158/1078-0432.CCR-15-0039

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

PMC publication ID

6063985

0 references

PubMed publication ID

26473188

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26473188

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/26473188

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46111530&oldid=2093232385"